Shifting the paradigm

Where technology meets Human

Volv Global personalises healthcare by providing insights on patients and diseases powered by data-driven AI and machine learning.

Our custom, proprietary, machine learning algorithms power a suite of services for pharmaceutical companies that reduces costs throughout the healthcare ecosystem and improves outcomes for those living with disease.

Personalise the
patient journey

Stratify and triage patients for individualised and optimised treatment, saving time, cost and the emotional burden of incorrect diagnosis.

Target patient populations

Characterise, segment and target patient cohorts to make clinical development and commercialisation more efficient and cost-effective.

Expand medical knowledge

Generate novel insights and new understanding of patient biomarkers, phenotypes, clinical features and endpoints.

Healthcare
efficiencies

Optimise resource allocation and reduce cost impact of incorrect or late diagnoses, while maximising quality of life and outcomes.

Volv Global helps you work smarter

Adding value through unprecedented insights

Volv Global uses AI and population-scale data to generate knowledge and insights into difficult-to-diagnose diseases that others cannot match. Our clients can leverage these insights to enhance clinical development strategies, enrich disease understanding, and gain an edge over their rivals. Our insights help identify opportunities to rapidly develop diagnostic tools, reposition existing drugs that increase R&D viability, so our clients can target new markets, work smarter and drive profitability.

Volv Global,
in numbers

billion medical
events

billion person-years
of health data

published first
AI/ML papers

Volv Global delivers high-value solutions at speed

Impact across the product lifecycle

Clinical
Development

De-risk clinical strategy & improve robustness of trial planning.

Value and
Access, HEOR

Generate meaningful and valuable real-world evidence.

Medical
Affairs

Expand the boundaries of medical understanding with new RWD insights.

Commercial
Excellence

Launch strongly and extend the product lifecycle by finding more patients.

Introducing inTrigue

Advanced, proprietary machine learning technology for patient-disease insights

With inTrigue, our flagship machine learning methodology, Volv Global transforms disease management and treatment at the individual patient level, along the patient journey and optimising patient outcomes.

Shaping the future today for a better tomorrow

Understanding patient phenomenology, across all diseases.

Volv Global’s suite of services

We find
more
patients

We ensure that all patients are offered the right treatment options and increase the pool of RWD on a disease.

We detect
diseases at an
earlier stage

We detect subtle patterns among biomarkers to predict disease incidence early, sometimes years ahead of time.

We predict
patient
outcomes

We model disease progression and are able to provide prognoses, instead of diagnoses.

We stratify
patient
cohorts

We detect, cluster and differentiate sub-groups within a heterogenous patient cohort, to learn more about disease pathways.

The human story

Improving lives with better tools and treatments

Volv Global helps transform lives by giving pharmaceutical innovators powerful insights into difficult-to-diagnose diseases so they can develop effective tools and treatments. To the patient this might look like earlier diagnosis, a lifechanging drug or the opportunity to connect with a wider community for education and support as they navigate life with a rare disease.

Stay informed

Insights & Events

Conference Posters: ATS 2025, 17-21 May

- 17/04/2025

Conference Poster: Swiss Biotech Day 2025, 5th-6th May

- 05/04/2025

Unlocking the Power of EMR Data for Earlier Gastric Cancer Diagnosis and Risk Prediction

- 11/03/2025

Press Release: Volv Global Expands Office Footprint to Power Next-Generation AI Innovation in Healthcare

- 05/03/2025

A Rare Disease Day Message from Dr. Al Freedman

- 28/02/2025